A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment seralutinib.

Pulmonary hypertension (PH) is characterized by high blood pressure, which affects the pulmonary arteries, the vessels that transport blood from the heart to the lungs. Due to the thickened and ...

Opsumit (macitentan), an oral once-daily therapy, is approved to treat the symptoms and help slow the progression of PAH. It is also being investigated as a possible treatment for other types PH, ...

Reata plans to present more detailed findings from CATALYST, including a full analysis of the data, at a future medical conference. Bardoxolone methyl is also being investigated in people with kidney ...